GenomeNet

Database: UniProt
Entry: CGT2_CAEEL
LinkDB: CGT2_CAEEL
Original site: CGT2_CAEEL 
ID   CGT2_CAEEL              Reviewed;         443 AA.
AC   G5EC84;
DT   06-MAR-2013, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   27-MAR-2024, entry version 75.
DE   RecName: Full=Ceramide glucosyltransferase 2;
DE            Short=CGT-2 {ECO:0000303|PubMed:19240113, ECO:0000303|PubMed:21325339};
DE            EC=2.4.1.80 {ECO:0000269|PubMed:21325339};
GN   Name=cgt-2; ORFNames=F20B4.6;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=11443131; DOI=10.1074/jbc.m104952200;
RA   Leipelt M., Warnecke D., Zahringer U., Ott C., Muller F., Hube B.,
RA   Heinz E.;
RT   "Glucosylceramide synthases, a gene family responsible for the biosynthesis
RT   of glucosphingolipids in animals, plants, and fungi.";
RL   J. Biol. Chem. 276:33621-33629(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION.
RX   PubMed=7651085; DOI=10.1007/bf02537032;
RA   Chitwood D.J., Lusby W.R., Thompson M.J., Kochansky J.P., Howarth O.W.;
RT   "The glycosylceramides of the nematode Caenorhabditis elegans contain an
RT   unusual, branched-chain sphingoid base.";
RL   Lipids 30:567-573(1995).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=19240113; DOI=10.1242/jcs.042754;
RA   Marza E., Simonsen K.T., Faergeman N.J., Lesa G.M.;
RT   "Expression of ceramide glucosyltransferases, which are essential for
RT   glycosphingolipid synthesis, is only required in a small subset of C.
RT   elegans cells.";
RL   J. Cell Sci. 122:822-833(2009).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=21325339; DOI=10.1093/glycob/cwr019;
RA   Nomura K.H., Murata D., Hayashi Y., Dejima K., Mizuguchi S.,
RA   Kage-Nakadai E., Gengyo-Ando K., Mitani S., Hirabayashi Y., Ito M.,
RA   Nomura K.;
RT   "Ceramide glucosyltransferase of the nematode Caenorhabditis elegans is
RT   involved in oocyte formation and in early embryonic cell division.";
RL   Glycobiology 21:834-848(2011).
CC   -!- FUNCTION: Catalyzes the first glycosylation step in glycosphingolipid
CC       biosynthesis, the transfer of glucose to ceramide to produce
CC       glucosylceramides (GlcCer). GlcCer are known to contribute to the
CC       physical properties and physiological functions of membranes and may
CC       regulate signal transduction (PubMed:11443131, PubMed:19240113,
CC       PubMed:21325339). Only branched-chain sphingoid bases like 15-
CC       methylhexadecasphing-4-enine are used for generating complex
CC       sphingolipids in Caenorhabditis elegans (PubMed:7651085).
CC       {ECO:0000269|PubMed:11443131, ECO:0000269|PubMed:19240113,
CC       ECO:0000269|PubMed:21325339, ECO:0000269|PubMed:7651085}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphing-4-enine + UDP-alpha-D-glucose = a beta-D-
CC         glucosyl-(1<->1')-N-acylsphing-4-enine + H(+) + UDP;
CC         Xref=Rhea:RHEA:12088, ChEBI:CHEBI:15378, ChEBI:CHEBI:22801,
CC         ChEBI:CHEBI:52639, ChEBI:CHEBI:58223, ChEBI:CHEBI:58885; EC=2.4.1.80;
CC         Evidence={ECO:0000269|PubMed:11443131, ECO:0000269|PubMed:21325339};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12089;
CC         Evidence={ECO:0000269|PubMed:11443131, ECO:0000269|PubMed:21325339};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-acyl-15-methylhexadecasphing-4-enine + UDP-alpha-D-glucose =
CC         H(+) + N-acyl-1-beta-D-glucosyl-15-methylhexadecasphing-4-enine +
CC         UDP; Xref=Rhea:RHEA:34611, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:58885, ChEBI:CHEBI:70815, ChEBI:CHEBI:70846;
CC         Evidence={ECO:0000305|PubMed:11443131, ECO:0000305|PubMed:19240113,
CC         ECO:0000305|PubMed:21325339};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34612;
CC         Evidence={ECO:0000305|PubMed:11443131, ECO:0000305|PubMed:19240113,
CC         ECO:0000305|PubMed:21325339};
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC       {ECO:0000269|PubMed:19240113, ECO:0000269|PubMed:21325339,
CC       ECO:0000305|PubMed:11443131}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed mostly in intestine and vulva.
CC       {ECO:0000305|PubMed:21325339}.
CC   -!- DOMAIN: The D1, D2, D3, (Q/R)XXRW motif is a critical part of the GCS
CC       active site, involved in catalysis and UDP-sugar binding.
CC       {ECO:0000250|UniProtKB:Q9R0E0}.
CC   -!- DISRUPTION PHENOTYPE: Reduced brood size.
CC       {ECO:0000269|PubMed:21325339}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF364401; AAK73018.1; -; mRNA.
DR   EMBL; FO081185; CCD69753.1; -; Genomic_DNA.
DR   PIR; T28827; T28827.
DR   RefSeq; NP_510857.2; NM_078456.4.
DR   AlphaFoldDB; G5EC84; -.
DR   BioGRID; 46661; 2.
DR   STRING; 6239.F20B4.6.1; -.
DR   SwissLipids; SLP:000000022; -.
DR   CAZy; GT21; Glycosyltransferase Family 21.
DR   PaxDb; 6239-F20B4-6; -.
DR   PeptideAtlas; G5EC84; -.
DR   EnsemblMetazoa; F20B4.6.1; F20B4.6.1; WBGene00017625.
DR   EnsemblMetazoa; F20B4.6.2; F20B4.6.2; WBGene00017625.
DR   GeneID; 181790; -.
DR   KEGG; cel:CELE_F20B4.6; -.
DR   AGR; WB:WBGene00017625; -.
DR   WormBase; F20B4.6; CE30960; WBGene00017625; cgt-2.
DR   eggNOG; KOG2547; Eukaryota.
DR   GeneTree; ENSGT00390000012898; -.
DR   HOGENOM; CLU_030898_0_0_1; -.
DR   InParanoid; G5EC84; -.
DR   OrthoDB; 2786173at2759; -.
DR   PhylomeDB; G5EC84; -.
DR   Reactome; R-CEL-9840309; Glycosphingolipid biosynthesis.
DR   UniPathway; UPA00222; -.
DR   PRO; PR:G5EC84; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00017625; Expressed in adult organism and 2 other cell types or tissues.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0008120; F:ceramide glucosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0102769; F:dihydroceramide glucosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006679; P:glucosylceramide biosynthetic process; IBA:GO_Central.
DR   CDD; cd02520; Glucosylceramide_synthase; 1.
DR   InterPro; IPR025993; Ceramide_glucosylTrfase.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR12726; CERAMIDE GLUCOSYLTRANSFERASE; 1.
DR   PANTHER; PTHR12726:SF0; CERAMIDE GLUCOSYLTRANSFERASE; 1.
DR   Pfam; PF13506; Glyco_transf_21; 1.
DR   SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1.
PE   1: Evidence at protein level;
KW   Glycosyltransferase; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Reference proteome; Sphingolipid metabolism; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..443
FT                   /note="Ceramide glucosyltransferase 2"
FT                   /id="PRO_0000421282"
FT   TRANSMEM        60..80
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        336..356
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        398..418
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           139
FT                   /note="D1"
FT                   /evidence="ECO:0000305"
FT   MOTIF           191
FT                   /note="D2"
FT                   /evidence="ECO:0000305"
FT   MOTIF           285
FT                   /note="D3"
FT                   /evidence="ECO:0000305"
FT   MOTIF           321..325
FT                   /note="(Q/R)XXRW"
FT                   /evidence="ECO:0000305"
FT   ACT_SITE        285
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0E0"
SQ   SEQUENCE   443 AA;  50121 MW;  2690419210CA6C93 CRC64;
     MGDKITGLEV EIIPEISEVQ PESLQEQNAS SLYYPLFSQY IPLLLTGTKK ILEDIDYCTC
     FAVFGVVFVS ALYFLHIVGL CYGKYRLHRP TKPNPSLPGV SIIKPIIGAD ANLYTNLETF
     FTTQYHKFEL LFCFDRSDDP AVKVVESLVK KYPSVDSTMF FGGEKIGLNP KINNMMPAYR
     IAKYQLIMIS DSGIFMKSDA VLDMASTMMS HETMALVTQT PYCKDRKGFA SVFEQIYFGT
     SHARIYLAGN CLQFNCPTGM SSMMKKEALD ECGGFAAFSG YLAEDYFFGK KLASRGYKSG
     ISTHPALQNS AAVTMTSFTD RVCRWVKLRM AMMPQIIFVE PLQDCFPSAL IISFSLNYIA
     NIDMLTTIML HVVFWITMDC MVMCKMQNKK MSFSPLKFLL IWLLRELFAP LVFIKAALDP
     SIRWRDNVFH LAWGGKIRSQ TSI
//
DBGET integrated database retrieval system